According to Rani Therapeutics's latest financial reports the company has C$43.17 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | C$0.13 B | -10.72% |
2021-12-31 | C$0.14 B | 60.69% |
2020-12-31 | C$93.15 M | 331.33% |
2019-12-31 | C$21.59 M |